Clinical trial
Evaluate the Potential of Montelukast to Prevent Nasal Symptomatology During…
NCT00189475 · Deborah Gentile, Other · Completed
Key facts
| NCT number | NCT00189475 |
|---|---|
| Title | Evaluate the Potential of Montelukast to Prevent Nasal Symptomatology During Colds |
| Official title | A Pilot Study to Evaluate the Potential of Montelukast to Prevent the Development of Nasal Symptomatology During Natural Viral Upper Respiratory Infections |
| Lead sponsor | Deborah Gentile, Other |
| Collaborators | Merck Sharp & Dohme LLC Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Upper Respiratory Infection |
| Intervention type | Drug |
| Interventions | Montelukast, Placebo |
| Enrollment | 84 |
| Start date | Oct 1, 2003 |
| Primary completion | Jul 1, 2007 |
| Completion | Jul 1, 2007 |
| First posted | Sep 19, 2005 |
| Last update posted | Nov 18, 2020 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: